ID

29838

Descrição

The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01049009

Link

https://clinicaltrials.gov/show/NCT01049009

Palavras-chave

Versões (1)
  1. 23/04/2018 23/04/2018 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

23 de abril de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility High Blood Pressure NCT01049009

Inglês

Eligibility High Blood Pressure NCT01049009

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or post-menopausal females aged 18-80 years.
Descrição

Age | Postmenopausal state

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0232970
subjects self-identified as black or african-american.
Descrição

Black | African American

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0005680
UMLS CUI [2]
C0085756
diagnosis of hypertension.
Descrição

Hypertensive disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0020538
patients on current anti-hypertensive therapy that does not include beta blockade should have bp >135/85.
Descrição

Antihypertensive therapy | Adrenergic beta-1 Receptor Antagonists Excluded | Blood pressure determination

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0585941
UMLS CUI [2,1]
C0304516
UMLS CUI [2,2]
C0332196
UMLS CUI [3]
C0005824
patients on anti-hypertensive therapy including beta blockers will have their beta blockers discontinued gradually over 2 weeks before enrolment.
Descrição

Antihypertensive therapy | Adrenergic beta-1 Receptor Antagonists Discontinued Gradual

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0585941
UMLS CUI [2,1]
C0304516
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C0439833
concomitant therapy: patients will be allowed to be on concomitant therapy with aspirin, statins, thiazide diuretics, calcium antagonists (for treatment of hypertension), clonidine, or vasodilators. patients will be on stable medical therapy for at least 2 months before recruitment. patients with previous treatment with beta adrenergic blockers (metoprolol, propranolol, atenolol, and labetalol) will also be eligible to participate, but will be randomized to the study beta blocker.
Descrição

Aspirin | Statins | Thiazide Diuretics | Calcium Channel Blockers Hypertensive disease | Clonidine | Vasodilator Agents | Therapeutic procedure Stable | Adrenergic beta-1 Receptor Antagonists | Metoprolol | Propranolol | Atenolol | Labetalol

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0004057
UMLS CUI [2]
C0360714
UMLS CUI [3]
C0012802
UMLS CUI [4,1]
C0006684
UMLS CUI [4,2]
C0020538
UMLS CUI [5]
C0009014
UMLS CUI [6]
C0042402
UMLS CUI [7,1]
C0087111
UMLS CUI [7,2]
C0205360
UMLS CUI [8]
C0304516
UMLS CUI [9]
C0025859
UMLS CUI [10]
C0033497
UMLS CUI [11]
C0004147
UMLS CUI [12]
C0022860
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
initiation or change in dose of statin or other anti-hypertensive therapy within 2 months before the study
Descrição

Initiation Statin | Statin Dose Change | Initiation Antihypertensive therapy | Antihypertensive therapy Dose Change

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1704686
UMLS CUI [1,2]
C0360714
UMLS CUI [2,1]
C0360714
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0392747
UMLS CUI [3,1]
C1704686
UMLS CUI [3,2]
C0585941
UMLS CUI [4,1]
C0585941
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0392747
inability to return to emory for follow-up testing
Descrição

Follow-up Testing Unsuccessful

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3274571
UMLS CUI [1,2]
C0039593
UMLS CUI [1,3]
C1272705
age < 21 or >80 years
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
premenopausal females with potential for pregnancy
Descrição

Premenopausal state | Childbearing Potential

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C3831118
acute infection in previous 2 weeks
Descrição

Communicable Disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0009450
on angiotensin antagonists (ace inhibitors or arbs)
Descrição

Angiotensin Receptor Antagonists | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0815017
UMLS CUI [2]
C0003015
UMLS CUI [3]
C0521942
history of substance abuse
Descrição

Substance Use Disorders

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0038586
current neoplasm
Descrição

Neoplasm

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0027651
chronic renal failure [creatinine > 2.5 mg/dl] or liver failure (liver enzymes >2x normal)
Descrição

Kidney Failure, Chronic | Creatinine measurement, serum | Chronic Liver Failure | Elevated liver enzymes

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0022661
UMLS CUI [2]
C0201976
UMLS CUI [3]
C2936476
UMLS CUI [4]
C0235996
acute coronary syndrome, class iv heart failure, cva, coronary intervention within 2 months
Descrição

Acute Coronary Syndrome | Heart failure New York Heart Association Classification | Cerebrovascular accident | Intervention Coronary

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0948089
UMLS CUI [2,1]
C0018801
UMLS CUI [2,2]
C1275491
UMLS CUI [3]
C0038454
UMLS CUI [4,1]
C0184661
UMLS CUI [4,2]
C1522318
known aortic stenosis, hypertrophic cardiomyopathy.
Descrição

Aortic Stenosis | Hypertrophic Cardiomyopathy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0003507
UMLS CUI [2]
C0007194
inability to give informed consent
Descrição

Informed Consent Unable

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
Voltar ao início da página

Similar models

Eligibility High Blood Pressure NCT01049009

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Age | Postmenopausal state
Item
male or post-menopausal females aged 18-80 years.
boolean
C0001779 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
Black | African American
Item
subjects self-identified as black or african-american.
boolean
C0005680 (UMLS CUI [1])
C0085756 (UMLS CUI [2])
Hypertensive disease
Item
diagnosis of hypertension.
boolean
C0020538 (UMLS CUI [1])
Antihypertensive therapy | Adrenergic beta-1 Receptor Antagonists Excluded | Blood pressure determination
Item
patients on current anti-hypertensive therapy that does not include beta blockade should have bp >135/85.
boolean
C0585941 (UMLS CUI [1])
C0304516 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C0005824 (UMLS CUI [3])
Antihypertensive therapy | Adrenergic beta-1 Receptor Antagonists Discontinued Gradual
Item
patients on anti-hypertensive therapy including beta blockers will have their beta blockers discontinued gradually over 2 weeks before enrolment.
boolean
C0585941 (UMLS CUI [1])
C0304516 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0439833 (UMLS CUI [2,3])
Aspirin | Statins | Thiazide Diuretics | Calcium Channel Blockers Hypertensive disease | Clonidine | Vasodilator Agents | Therapeutic procedure Stable | Adrenergic beta-1 Receptor Antagonists | Metoprolol | Propranolol | Atenolol | Labetalol
Item
concomitant therapy: patients will be allowed to be on concomitant therapy with aspirin, statins, thiazide diuretics, calcium antagonists (for treatment of hypertension), clonidine, or vasodilators. patients will be on stable medical therapy for at least 2 months before recruitment. patients with previous treatment with beta adrenergic blockers (metoprolol, propranolol, atenolol, and labetalol) will also be eligible to participate, but will be randomized to the study beta blocker.
boolean
C0004057 (UMLS CUI [1])
C0360714 (UMLS CUI [2])
C0012802 (UMLS CUI [3])
C0006684 (UMLS CUI [4,1])
C0020538 (UMLS CUI [4,2])
C0009014 (UMLS CUI [5])
C0042402 (UMLS CUI [6])
C0087111 (UMLS CUI [7,1])
C0205360 (UMLS CUI [7,2])
C0304516 (UMLS CUI [8])
C0025859 (UMLS CUI [9])
C0033497 (UMLS CUI [10])
C0004147 (UMLS CUI [11])
C0022860 (UMLS CUI [12])
Item Group
C0680251 (UMLS CUI)
Initiation Statin | Statin Dose Change | Initiation Antihypertensive therapy | Antihypertensive therapy Dose Change
Item
initiation or change in dose of statin or other anti-hypertensive therapy within 2 months before the study
boolean
C1704686 (UMLS CUI [1,1])
C0360714 (UMLS CUI [1,2])
C0360714 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
C1704686 (UMLS CUI [3,1])
C0585941 (UMLS CUI [3,2])
C0585941 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0392747 (UMLS CUI [4,3])
Follow-up Testing Unsuccessful
Item
inability to return to emory for follow-up testing
boolean
C3274571 (UMLS CUI [1,1])
C0039593 (UMLS CUI [1,2])
C1272705 (UMLS CUI [1,3])
Age
Item
age < 21 or >80 years
boolean
C0001779 (UMLS CUI [1])
Premenopausal state | Childbearing Potential
Item
premenopausal females with potential for pregnancy
boolean
C0232969 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
Communicable Disease
Item
acute infection in previous 2 weeks
boolean
C0009450 (UMLS CUI [1])
Angiotensin Receptor Antagonists | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
on angiotensin antagonists (ace inhibitors or arbs)
boolean
C0815017 (UMLS CUI [1])
C0003015 (UMLS CUI [2])
C0521942 (UMLS CUI [3])
Substance Use Disorders
Item
history of substance abuse
boolean
C0038586 (UMLS CUI [1])
Neoplasm
Item
current neoplasm
boolean
C0027651 (UMLS CUI [1])
Kidney Failure, Chronic | Creatinine measurement, serum | Chronic Liver Failure | Elevated liver enzymes
Item
chronic renal failure [creatinine > 2.5 mg/dl] or liver failure (liver enzymes >2x normal)
boolean
C0022661 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C2936476 (UMLS CUI [3])
C0235996 (UMLS CUI [4])
Acute Coronary Syndrome | Heart failure New York Heart Association Classification | Cerebrovascular accident | Intervention Coronary
Item
acute coronary syndrome, class iv heart failure, cva, coronary intervention within 2 months
boolean
C0948089 (UMLS CUI [1])
C0018801 (UMLS CUI [2,1])
C1275491 (UMLS CUI [2,2])
C0038454 (UMLS CUI [3])
C0184661 (UMLS CUI [4,1])
C1522318 (UMLS CUI [4,2])
Aortic Stenosis | Hypertrophic Cardiomyopathy
Item
known aortic stenosis, hypertrophic cardiomyopathy.
boolean
C0003507 (UMLS CUI [1])
C0007194 (UMLS CUI [2])
Informed Consent Unable
Item
inability to give informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial